Eupraxia Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Update
Announced first patient dosed in the Phase 2b placebo-controlled portion of the…
Residential Real Estate Buyer Brokerage Commissions Class Actions – Class Action Notice of Proposed Settlement and Ancillary Relief and Opt-Out Deadline
LONDON, ON, Aug. 12, 2025 /PRNewswire/ -- Did you sell residential real…
Quipt Home Medical Reports Improved Fiscal Third Quarter 2025 Results
Posts Positive Organic Growth and Adjusted EBITDA‎1 of 23.5% of Revenue CINCINNATI,…
Anteris Announces Results for the Second Quarter of 2025
MINNEAPOLIS and BRISBANE, Australia, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Anteris Technologies…
Rumble Reports Second Quarter 2025 Results
~ Revenue up 12% Year-over-Year to $25.1 Million ~ ~ Quarter Concluded…
RadNet Reports Second Quarter Financial Results with Record Quarterly Revenue and Adjusted EBITDA and Revises Upwards 2025 Financial Guidance Ranges
Total Company Revenue increased 8.4% to a quarterly record of $498.2 million…
Intermap Announces Date for Second Quarter Earnings
Company will announce second quarter 2025 financial results and host a conference…
Sandoz delivers strong H1 2025 results, with accelerated sales growth in the second quarter
Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules…
Aicuris Presents Pharmacokinetic Data from the First-in-Human Clinical Trial of AIC468, a Novel Antisense Oligonucleotide Targeting BK Virus, at World Transplant Congress
Initial results from the First in Human (FIH) Phase 1 trial evaluating…
BioNTech Announces Second Quarter 2025 Financial Results and Corporate Update
Continued execution of BioNTech’s oncology strategy with focus on two pan-tumor programs…